Showing 7791-7800 of 10166 results for "".
- NIH Awards Icahn School of Medicine at Mount Sinai $2.7 Million for Eczema Researchhttps://practicaldermatology.com/news/20131126-nih_awards_icahn_school_of_medicine_at_mount_sinai_27_million_for_eczema_research/2459404/
- Actelion Launches Valchlor to Treat Stage IA and IB Mycosis Fungoides-type Cutaneous T-cell Lymphomahttps://practicaldermatology.com/news/20131119-actelion_launches_valchlor_to_treat_stage_ia_and_ib_mycosis_fungoides-type_cutaneous_t-cell_lymphoma/2459409/The FDA approved Actelion's Valchlor (mechlorethamine), the first and only FDA-approved topical formulation of mechlorethamine. Valchlor, a gel that is applied topically once a day, is an alkylating drug indicated to treat p
- Merz Pharma Group Acquires Anteis S.A.https://practicaldermatology.com/news/20131112-merz_pharma_group_acquires_anteis_sa/2459418/
- Modernizing Medicine and Miraca Life Sciences Partner to Create Enhanced EMR and Pathology Lab Integrationhttps://practicaldermatology.com/news/20130926-modernizing_medicine_and_miraca_life_sciences_partner_to_create_enhanced_emr_and_pathology_lab_integration/2459448/
- Rosacea Concierge Offers Patient Support and Resourceshttps://practicaldermatology.com/news/20130924-rosacea_concierge_offers_patient_support_and_resources/2459453/Bayer HealthCare recently launched Rosacea Concierge, a new resource for the estimated 16 million people living with rosacea. The new, easy-to-navigate www.RosaceaConcierge.com includes information on rosacea in the form of video tutorials from a team of experts, including a der
- Do Physicians Mention Sunscreen Use Often Enough at Patient Visits?https://practicaldermatology.com/news/20130905-do_physicians_mention_sunscreen_use_often_enough_at_patient_visits/2459468/
- FDA Approves Valchlor Gel for the Treatment of Stage IA and IB Mycosis Fungoides-Type CTCLhttps://practicaldermatology.com/news/20130826-fda_approves_valchlor_gel_for_the_treatment_of_stage_ia_and_ib_mycosis_fungoides-type_ctcl/2459475/
- Acne-Specific Dermatology Platform Site Goes Livehttps://practicaldermatology.com/news/20130801-acne-specific_dermatology_platform_site_goes_live/2459485/
- Merz North America Appoints New Vice Presidenthttps://practicaldermatology.com/news/20130702-merz_north_america_appoints_new_vice_president/2459503/Greg Besase has been appointed Vice President of Merz North America. Besase joined Merz in December 2012 as Director of Marketing, Dermatology and has served as the interim head of the U.S. Dermatology Business Unit since February 2013.
- Renaissance and GlaxoSmithKline Transfer Nine Productshttps://practicaldermatology.com/news/20130605-renaissance_and_glaxosmithkline_transfer_nine_products/2459522/Renaissance Acquisition Holdings, LLC and GlaxoSmithKline entered into an agreement giving Renaissance the rights in the USA to manufacture, market, and sell six dermatology and three anti-viral products from GSK. The products from GSK and Stiefel, which will be marketed through Renaissance's bran